Amgen Exercises Option for Exclusive License to Cytokinetics' Cardiac Contractility Program That Includes ... (r repeated acute episodes. Despite curre...)

Amgen Exercises Option for Exclusive License to Cytokinetics' Cardiac Contractility Program That Includes CK-1827452

Date:5/26/2009

r repeated acute episodes. Despite currently available therapies, readmission rates for heart failure patients over the age of 65 are as high as 42 percent within one year of hospital discharge. Mortality rates over the five-year period following a diagnosis of heart failure are approximately 60 percent. The high morbidity and mortality in the setting of current therapies points to the need for novel therapeutics that offer further reductions in morbidity and mortality. The annual cost of heart failure to the U.S. health care system is estimated to be $35 billion dollars. A portion of that cost is attributable to drugs used to treat each of chronic and acute heart failure. Sales of drugs to treat chronic heart failure reached almost $2.5 billion in 2006 while sales of drugs to treat acute heart failure reached over $350 million in 2007.

About Amgen

Amgen discovers, develops, manufactures, and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and our vital medicines, visit www.amgen.com.

About Cytokinetics

Cytokinetics is a clinical-stage biopharmaceutical company focused on the discovery and development of novel small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditions. The company's drug candidates and poten
'/>"/>

SOURCE Amgen
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12
Related biology technology :

1. Amgen Announces Voting Results Of Annual Meeting Of Stockholders
2. Photos: Amgen and ONSEdge Partner With Cancer Survivor Jan Ping for New Campaign
3. Preclinical Data From Amgens Oncology Pipeline to be Presented at AACR
4. Amgen to Present at the Cowen and Company Annual Healthcare Conference
5. FDA Accepts Amgens Submission and Files Biologics License Application for Denosumab
6. Amgens Fourth Quarter 2008 Adjusted Earnings Per Share Increased 6 Percent to $1.06; Full Year 2008 Adjusted Earnings Per Share Increased 6 Percent to $4.55
7. Amgens Breakaway from Cancer Initiative Expands to Help Cancer Patients Access Broad Spectrum of Cancer Resources and Services
8. Amgen Announces Webcast of 2008 Fourth Quarter and Full Year Financial Results
9. Amgen to Present at the 27th Annual JP Morgan Healthcare Conference
10. Amgen Foundation Announces $2.5 Million Expansion of Amgen Scholars Program to Europe
11. Amgen Positioned to Deliver Attractive Growth Over Next Five Years

Post Your Comments:

(Date:12/15/2009)... the launch of several innovative new programs to aid ... current economic climate. The first is aimed at ... services over a period of 6, 12, 18, or ... companies. The second is aimed at more established ... 6 to 12 month period at discounted rates, and ...

(Date:12/14/2009)... Dec. 14 The third edition of ... , published by the Infusion Nurses ... for anthracycline extravasation.(1) Anthracyclines are a group ... epirubicin that have been used in the treatment ... 1970s.(2) ,, According to the INS ...

(Date:12/14/2009)... completed the delivery of Brookfield Engineering’s Powder Flow Tester – ... with a smaller footprint and more compact design. , ... ... -- ThermoFab, a US-based thermoforming company, has completed the delivery ... from sheet metal to a plastic enclosure with a smaller ...

(Date:12/11/2009)... 2009 -- Researchers have discovered a new explanation for differences ... excess copies of a certain gene, the more serious the ... it is suspected that it is the amount of copies ... being published in the American Journal of Human Genetics ... of Guy Froyen connected to VIB, a life sciences research ...

Breaking Biology Technology:The Prinz Law Office Launches Innovative New Programs to Aid Cash-Strapped Entrepreneurs and Businesses 2 Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 2 Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 3 Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 4 Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 5 Thermofab Helps Brookfield Engineering Move To A Compact Custom Plastic Enclosure 2 Amount of gene surplus determines severity of mental retardation in males 2

[0] The Prinz Law Office Launches Innovative New Programs to Aid Cash-Strapped Entrepreneurs and Businesses [0] Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation [0] Thermofab Helps Brookfield Engineering Move To A Compact Custom Plastic Enclosure [0] Amount of gene surplus determines severity of mental retardation in males

... months back I wrote about the negative effects of what ... problems in business can be solved by changing the way ... process management view of sorting out problems is simple ... as designed or wasnt designed properly in the first place. ...

... Red blood cells, some of which are affected by ... Wis. Third Wave Technologies , a Madison-based ... it has sued the California-based Stratagene Corp. ... it has patented the technology used in Stratagenes probe-based ...

... lunch in Chicago on Ontario Street with my young friend Jessica. ... she is six months into her first full-time job and already ... job lacks is career advancement, she told me. So this headhunter ... them about career advancement. She didnt even want me to use ...

Other Biology Technology:Human networks: an antidote to process ideology 2 Human networks: an antidote to process ideology 3 Human networks: an antidote to process ideology 4 Third Wave files patent infringement suit against Stratagene 2 Don't be muzzled in your Midwest technology job search 2 Don't be muzzled in your Midwest technology job search 3

Human networks: an antidote to process ideology Third Wave files patent infringement suit against Stratagene Don't be muzzled in your Midwest technology job search

(Date:12/11/2009)... premium fruit increases, growers are being challenged to ... boost their bottom line, orchard owners are experimenting ... while reducing labor costs. , Hand thinning, a ... healthier fruit, is among the most labor-intensive of ... production overhead, and, ultimately, prices paid by consumers. ...

(Date:12/11/2009)... Scientists studying how bacteria under stress collectively weigh and ... insights into how humans make strategic decisions that affect ... society. , Their study, published this week in the ... the National Academy of Sciences , was accomplished when ... to describe the complex interplay of genes and proteins ...

(Date:12/11/2009)... two decades, Ivy Pike, an associate professor of anthropology ... groups in rural northern Kenya to understand how violence ... there. , The results of her and her colleagues, ... three pastoralist communities of northern Kenya: A conceptual framework," ... Social Science and Medicine , in collaboration with the ...

[0] Horizontal string trimmer reduces labor costs, increases peach size [0] Bacteria provide new insights into human decision making [0] UA-led study grapples with health effects of low-intensity warfare

... Chicago show how the bacteria that cause the plague manage ... one of the microbe's tools, the researchers produced what may ... -- one published online July 28 in Science Express and ... focus on aspects of the type-III pathway, a molecular syringe ...

... crop plants, scientists have deciphered the genome of a ... , The research provides clues to better explain how ... and seeds from infection by harmful microbes that cause ... Nature Biotechnology and was scheduled to be posted online ...

... of exactly how the brain controls breathing is fundamental ... breathing is an automatic rhythmic process that persists without ... the question that has intrigued many scientists for well ... safe vital rhythm throughout life? , Experimental Physiology editor ...

Other Biology News:Studies reveal how plague disables immune system, and how to exploit the process to make a vaccine 2 Studies reveal how plague disables immune system, and how to exploit the process to make a vaccine 3 Studies reveal how plague disables immune system, and how to exploit the process to make a vaccine 4 Genome study of beneficial microbe may help boost plant health 2 How exactly does the brain control breathing? 2

Studies reveal how plague disables immune system, and how to exploit the process to make a vaccine Genome study of beneficial microbe may help boost plant health How exactly does the brain control breathing?

Puromycin resistance gene (pac), provided in a pORF plasmid. pORF is an expression plasmid selectable with Ampicillin....

...

... template is designed to allow neomycin/kanamycin ... The loxP-PGK-gb2-neo-loxP template encodes the ... prokaryotic promoter (gb2) for expression of ... eukaryotic promoter (PGK) for expression of ...

... precision 5mm diameter, 7 inch long PYREX NMR ... compatibility with ground joints, valves, and vacuum racks. ... running from 300 to 500MHz. They have an ... of 4.20 + 0.013-0.000mm. These NMR tubes can ...

Biology Products:

pORF39-Pac from InvivoGen SkanWasher 400 from Molecular Devices loxP flanked, Pro and Euk. Neomycin Selection Cassette (loxP-PGK-gb2-neo-loxP) from Gene Bridges GmbH Pyrex brand 5mm diameter NMR tubes from Sigma-Aldrich

Amgen Exercises Option for Exclusive License to Cytokinetics' Cardiac Contractility Program That Includes ...(r repeated acute episodes. Despite curre...)